140324 Director PDMR Shareholding
24 March 2014 Omega Diagnostics Group PLC (“Omega” or the “Company”) Director/PDMR Shareholding Omega (AIM: ODX), the medical diagnostics company focused on allergy, food intolerance and infectious disease, announces that Kieron Harbinson, Group Finance Director, today purchased 40,000 ordinary shares in the Company at 28.5p per share. Following this transaction, Mr Harbinson’s total beneficial holding has increased to 363,562 ordinary shares representing 0.33 per cent of the issued ordinary share capital of the Company.
Contacts: Omega Diagnostics Group PLC Andrew Shepherd, Chief Executive Kieron Harbinson, Group Finance Director Jag Grewal, Group Sales and Marketing Director finnCap Ltd Geoff Nash/Christopher Raggett (Corporate Finance) Stephen Norcross/Mia Gardner (Corporate Broking) Walbrook PR Limited Paul McManus Lianne Cawthorne
Tel: 01259 763 030 www.omegadiagnostics.com
Tel: 020 7220 0500
Tel: 020 7933 8780 or [email protected] Mob: 07980 541 893 Mob: 07584 391 303
Contacts: Omega Diagnostics Group PLC Andrew Shepherd, Chief Executive Kieron Harbinson, Group Finance Director Jag Grewal, Group Sales and Marketing Director finnCap Ltd Geoff Nash/Christopher Raggett (Corporate Finance) Stephen Norcross/Mia Gardner (Corporate Broking) Walbrook PR Limited Paul McManus Lianne Cawthorne
Tel: 01259 763 030 www.omegadiagnostics.com
Tel: 020 7220 0500
Tel: 020 7933 8780 or [email protected] Mob: 07980 541 893 Mob: 07584 391 303
